Bausch + Lomb Corporation (BLCO)
NYSE: BLCO · Real-Time Price · USD
17.47
+0.04 (0.23%)
At close: Oct 23, 2026, 4:00 PM EDT
17.13
-0.34 (-1.95%)
After-hours: Oct 23, 2026, 7:32 PM EDT
Bausch + Lomb Employees
Bausch + Lomb had 13,000 employees as of December 31, 2025. The number of employees decreased by 500 or 3.70% compared to the previous year. That makes Bausch + Lomb the 2,687th largest employer in the world and 639th in the United States.
Employees
13,000
Change (1Y)
-500
Growth (1Y)
-3.70%
Revenue / Employee
$409,538
Profits / Employee
-$13,154
Market Cap
6.24B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 13,000 | -500 | -3.70% |
| Dec 31, 2024 | 13,500 | 200 | 1.50% |
| Dec 31, 2023 | 13,300 | 400 | 3.10% |
| Dec 31, 2022 | 12,900 | 400 | 3.20% |
| Dec 31, 2021 | 12,500 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Align Technology | 20,290 |
| Teleflex | 15,500 |
| The Cooper Companies | 15,000 |
| AptarGroup | 14,000 |
| ICU Medical | 13,000 |
| Envista Holdings | 12,000 |
| MiniMed Group | 8,000 |
| Merit Medical Systems | 7,500 |
BLCO News
- 13 days ago - Bausch + Lomb names Thomas Appio as interim CEO - TheFly
- 13 days ago - Bausch + Lomb, Bausch Health expect to raise FY26 adjusted EBITDA, ex IPR&D - TheFly
- 13 days ago - Bausch + Lomb and Bausch Health Announce Appointment of Thomas J. Appio as Interim Bausch + Lomb CEO, Expect to Raise Full-Year 2026 Guidance - Business Wire
- 19 days ago - Bausch + Lomb advances oral treatment for dry AMD after FDA meeting - TheFly
- 19 days ago - Bausch + Lomb Advances Novel Oral Treatment for Dry AMD Following Constructive FDA Meeting - Business Wire
- 19 days ago - Bausch + Lomb initiated with an Overweight at Barclays - TheFly
- 20 days ago - Bausch + Lomb Will Release Third-Quarter 2026 Financial Results on Oct. 28 - Business Wire
- 6 weeks ago - Bausch + Lomb announces European CE Mark approval of SeeLyra - TheFly